Translate
Translate this website into the following languages:



Close Tab
Donations
UC San Diego Health
menu iconMenu
search iconSearch

UCSD’s Palmer Taylor Awarded 2009 Axelrod Award in Pharmacology

 

November 17, 2008  |  

Palmer Taylor, Ph.D., associate vice chancellor for Health Sciences, and founding dean of the Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of California, San Diego, has been awarded the 2009 Julius Axelrod Award in Pharmacology by the American Society for Pharmacology and Experimental Therapeutics (ASPET).  Taylor also holds the Sandra & Monroe Trout Chair in Pharmacology.

Palmer Taylor, PhD

Palmer Taylor, Ph.D.

The Julius Axelrod Award was established to honor the memory of the eminent American pharmacologist and Nobel laureate, who shaped the fields of neuroscience, drug metabolism and biochemistry and who served as a mentor for numerous eminent scientists around the world. Presented annually for significant contributions to understanding the biochemical mechanisms underlying the pharmacological actions of drugs and for contributions to mentoring other pharmacologists, the award includes a $5,000 honorarium.   

Joan Heller Brown, Ph.D., chair of UC San Diego’s department of pharmacology, who nominated Taylor for the award, said “Palmer Taylor exemplifies all that an academic pharmacologists should aspire to be –a first rate research scientist, a superb mentor, a scholarly and enthusiastic teacher, and an individual dedicated to preserving, expanding  and promoting training in the pharmacological sciences.”

Taylor will deliver the Julius Axelrod Lecture at the Experimental Biology annual meeting in New Orleans in April 2009 and organize the Julius Axelrod Symposium in the following year.  

ASPET is a 4,800 member scientific society whose members conduct basic and clinical pharmacological research in academia, industry and the government.  Members research efforts help develop new medicines and therapeutic agents to fight existing and emerging diseases.  Taylor served as ASPET President from 1995 to 1996.

Taylor's research has been directed to signaling by a neurotransmitter called acetylcholine, used by the body’s nervous system to communicate and control nerve and muscle function. His group cloned the first acetylcholinesterase (AChE) gene over 20 years ago.  AChE is an enzyme involved in regulating acetylcholine levels in the nervous system.  This discovery was followed by analysis of its genomic DNA to delineate regulatory regions, the multiple splicing options and gene expression profiles in nerve and muscle. Taylor also studies the molecular recognition properties of the nicotinic acetylcholine receptor, a protein transducing acetylcholine signals.   Recently, his collaborative endeavors have uncovered much of what is known about the structure of neuroligin, a synaptic adhesion molecule associated with mutations found in autism. 

# # #

Media Contact: Debra Kain, 619-543-6163, ddkain@ucsd.edu




Media Contact

Share This Article


Related News

8/24/2016
While even the best wines eventually peak and turn to vinegar, a new study by researchers at University of California San Diego School of Medicine suggests a paradoxical trend in the mental health of ...
8/19/2016
Researchers at the University of California San Diego School of Medicine have found that a form of magnetic resonance imaging (MRI) that non-invasively measures fat density in the liver corresponds wi ...
8/19/2016
Rheumatoid arthritis patients taking medications that inhibit interleukin-1beta (IL-1beta), a molecule that stimulates the immune system, are 300 times more likely to experience invasive Group A Strep ...
8/18/2016
Concerns over the Zika virus have focused on pregnant women due to mounting evidence that it causes brain abnormalities in developing fetuses. However, new research in mice suggests that certain adult ...



Follow Us

Our bimonthly newsletter delivers healthy lifestyle tips, patient stories and research discovery news. Subscribe: